Meta-flux, founded in 2021, is an innovative player in the intersection of AI, Biotechnology, and Health Care, with its headquarters in Ireland. The company's slogan, "Meta-flux is an AI biologist for pharmaceutical drug development," succinctly captures its mission to revolutionize the pharmaceutical industry through cutting-edge technology.
Meta-flux's platform leverages AI and multi-omic data to facilitate adaptive experimentation, positioning itself as a pivotal tool in drug development. Their approach significantly accelerates the discovery phase, potentially reducing time-to-market for new therapeutics.
The company's potential has been recognized by a notable pool of investors. In a recent seed investment round on October 13, 2025, Meta-flux secured €1.80M from significant players such as Gilead Sciences, Indeed, Merck, senior executives from Pfizer, and technology leaders from Google and Amazon, alongside investor Fernando Ferrer.